(Q78635741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

The clinical role of prostate-specific membrane antigen (PSMA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1

Sam S Chang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Warren D W Heston

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

7-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Prostate-specific membrane antigen: evidence for the existence of a second related human gene

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Prostate cancer and prostate bed SPECT imaging with ProstaScint: semiquantitative correlation with prostatic biopsy results

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

111Indium-capromab pendetide unexpectedly localizes to renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2801%2900124-7

7 January 2021

10.1016/S1078-1439(01)00124-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12474535%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference